Cikkek nyilvánosan hozzáférhető megbízással - Pinar Karaca MandicTovábbi információ
Sehol sem hozzáférhető: 7
Trends in omalizumab utilization for asthma: evidence of suboptimal patient selection
MM Jeffery, ND Shah, P Karaca-Mandic, JS Ross, MA Rank
The Journal of Allergy and Clinical Immunology: In Practice 6 (5), 1568-1577. e4, 2018
Megbízások: US National Science Foundation, US National Institutes of Health, Patient …
Family out-of-pocket health care burden and children's unmet needs or delayed health care
P Karaca-Mandic, SJ Choi-Yoo, J Lee, P Scal
Academic Pediatrics 14 (1), 101-108, 2014
Megbízások: US National Institutes of Health
State-based marketplaces using ‘clearinghouse’plan management models are associated with lower premiums
K Krinn, P Karaca-Mandic, LA Blewett
Health Affairs 34 (1), 161-169, 2015
Megbízások: US National Institutes of Health
Recession led to a decline in out-of-pocket spending for children with special health care needs
P Karaca-Mandic, SJ Choi Yoo, BD Sommers
Health Affairs 32 (6), 1054-1062, 2013
Megbízások: US National Institutes of Health
Biosimilar filgrastim uptake and costs among commercially insured, Medicare Advantage
P Karaca-Mandic, J Chang, R Go, S Schondelmeyer, D Weisdorf, ...
Health Affairs 38 (11), 1887-1892, 2019
Megbízások: US National Institutes of Health
States with stronger health insurance rate review authority experienced lower premiums in the individual market in 2010–13
P Karaca-Mandic, BD Fulton, A Hollingshead, RM Scheffler
Health Affairs 34 (8), 1358-1367, 2015
Megbízások: US National Institutes of Health
Uptake of biosimilar among privately insured patients undergoing infliximab treatment
J Chang, P Karaca-Mandic, MM Jeffery
Medical care 61 (10), 636-643, 2023
Megbízások: US National Institutes of Health
Valahol hozzáférhető: 49
Assessment of COVID-19 hospitalizations by race/ethnicity in 12 states
P Karaca-Mandic, A Georgiou, S Sen
JAMA internal medicine 181 (1), 131-134, 2021
Megbízások: US National Institutes of Health
Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims
AB Jena, D Goldman, L Weaver, P Karaca-Mandic
Bmj 348, 2014
Megbízások: US National Institutes of Health
Less intense postacute care, better outcomes for enrollees in Medicare Advantage than those in fee-for-service
PJ Huckfeldt, JJ Escarce, B Rabideau, P Karaca-Mandic, N Sood
Health Affairs 36 (1), 91-100, 2017
Megbízások: US National Institutes of Health
Out-of-pocket medication costs and use of medications and health care services among children with asthma
P Karaca-Mandic, AB Jena, GF Joyce, DP Goldman
Jama 307 (12), 1284-1291, 2012
Megbízások: US National Institutes of Health
Adoption of new glucose-lowering medications in the US—the case of SGLT2 inhibitors: nationwide cohort study
RG McCoy, HJ Dykhoff, L Sangaralingham, JS Ross, P Karaca-Mandic, ...
Diabetes technology & therapeutics 21 (12), 702-712, 2019
Megbízások: US National Science Foundation, US National Institutes of Health, Arnold …
Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs
KM Brayton, AT Hirsch, PJ O′ Brien, A Cheville, P Karaca-Mandic, ...
PLoS One 9 (12), e114597, 2014
Megbízások: US National Institutes of Health
Hospital prescribing of opioids to Medicare beneficiaries
AB Jena, D Goldman, P Karaca-Mandic
JAMA internal medicine 176 (7), 990-997, 2016
Megbízások: US National Institutes of Health
Behavioral impact of graduated driver licensing on teenage driving risk and exposure
P Karaca-Mandic, G Ridgeway
Journal of health economics 29 (1), 48-61, 2010
Megbízások: US National Institutes of Health
Comparison of diabetes medications used by adults with commercial insurance vs Medicare Advantage, 2016 to 2019
RG McCoy, HK Van Houten, Y Deng, PK Mandic, JS Ross, VM Montori, ...
JAMA network open 4 (2), e2035792-e2035792, 2021
Megbízások: US National Institutes of Health
Health and health risks among sexual minority women: An examination of 3 subgroups
JM Przedworski, DD McAlpine, P Karaca-Mandic, NA VanKim
American journal of public health 104 (6), 1045-1047, 2014
Megbízások: US National Institutes of Health
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis
P Karaca‐Mandic, GF Joyce, DP Goldman, M Laouri
Health services research 45 (5p1), 1227-1250, 2010
Megbízások: US National Institutes of Health
Rates of physician coprescribing of opioids and benzodiazepines after the release of the centers for disease control and prevention guidelines in 2016
MM Jeffery, WM Hooten, AB Jena, JS Ross, ND Shah, P Karaca-Mandic
JAMA network open 2 (8), e198325-e198325, 2019
Megbízások: US National Institutes of Health
Second-line therapy for type 2 diabetes management: the treatment/benefit paradox of cardiovascular and kidney comorbidities
RG McCoy, HK Van Houten, P Karaca-Mandic, JS Ross, VM Montori, ...
Diabetes Care 44 (10), 2302-2311, 2021
Megbízások: US National Science Foundation, US National Institutes of Health, Patient …
A publikációs és a finanszírozási adatokat számítógépes program határozza meg, automatikusan.